ARCHIVES

Afinitor Approved for Rare Disorder

This article is from The Cancer Letter archive.

Vol. 36 No. 40 | November 5, 2010

Download PDF Visit The Full Archive

Related Articles

NCI Planning To Switch Drug Development Emphasis From Compound To Human Cancer Oriented Strategy

October 26, 1984

Centers: Bookman Leaves Fox Chase for Arizona

September 11, 2009

Recompetition of $1.9 Mil. Primate Contract Approved

November 15, 1985

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

August 26, 2005

NIH Updates Policy On Large Grants

May 10, 1996

New Approach To Replacing Immune Cells Shrinks Tumors

September 27, 2002